Physician profile
Von L Evans
NPI 1467484600
$9,195.88
in general payments reported to CMS, 2019-2025
8 companies · $349 in 2025
The $349 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $216 · 2020: $7,407 · 2021: $205 · 2022: $254 · 2023: $423 · 2024: $340 · 2025: $349.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $938 · Consulting Fee: $175.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $937.73 |
| Consulting Fee | $175.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $8,773.46 | 2019-2025 | Mako, T2, Hydroset |
| Amgen INC. | $234.39 | 2020-2025 | Prolia, Krystexxa |
| Smith+Nephew, INC. | $81.27 | 2020 | |
| Zimmer Biomet Holdings, INC. | $31.31 | 2022 | |
| Innovation Technologies INC | $24.78 | 2024 | Irrisept |
| Abbott Laboratories | $20.30 | 2024 | Proclaim |
| Pacira Pharmaceuticals Incorporated | $18.92 | 2020 | |
| Horizon Therapeutics Plc | $11.45 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Von Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.